Reed Thomas D.
Chief Science Officer at PGEN
- Sold, on record
- $1.3M
- Dollars the filings state
- Form 4 sales
- 8
- Latest Jan 6, 2020
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- PGENPRECIGEN, INC.Chief Science Officer
Sales by reason
0
Routine
6
Plan not stated
0
No plan
2
Unusual
Form 4 sales per year, every sale on record.
Timeline
- Jan 6, 2020Plan not stated
Sold 3.5% of their holdings
$32k5,416 shares at $5.83
- Jan 3, 2020Plan not stated
Sold 2.2% of their holdings
$17k2,986 shares at $5.77
- Jan 2, 2020Plan not stated
Sold 2.7% of their holdings
$20k3,533 shares at $5.60
- Oct 1, 2019Plan not stated
Sold 3% of their holdings
$20k3,658 shares at $5.50
- Jul 1, 2019Plan not stated
Sold 3.2% of their holdings
$27k3,527 shares at $7.76
- Mar 5, 2019Unusual
Sold 84.5% of their holdings
$954k227,800 shares at $4.19
- Jan 3, 2019Plan not stated
Sold 3.6% of their holdings
$21k2,944 shares at $7.07
- Dec 31, 2018Unusual
Sold 29.2% of their holdings
$191k30,000 shares at $6.36
8 of 8
Every transaction
| Traded | Filed | Stock | Role | What | Amount | Price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|---|---|
| Jan 6, 2020 | Jan 7, 2020 | PGEN | Chief Science Officer | Sold | 5,416 | $5.83 | $32k | 148,888 | SEC |
| Jan 4, 2020 | Jan 7, 2020 | PGEN | Chief Science Officer | Exercised or settledRestricted Stock Units | 18,940 | 56,818 | SEC | ||
| Jan 4, 2020 | Jan 7, 2020 | PGEN | Chief Science Officer | Exercised options | 18,940 | 154,304 | SEC | ||
| Jan 3, 2020 | Jan 6, 2020 | PGEN | Chief Science Officer | Sold | 2,986 | $5.77 | $17k | 135,364 | SEC |
| Jan 2, 2020 | Jan 6, 2020 | PGEN | Chief Science Officer | Exercised or settledRestricted Stock Units | 9,766 | 19,531 | SEC | ||
| Jan 2, 2020 | Jan 6, 2020 | PGEN | Chief Science Officer | Exercised options | 9,766 | 138,350 | SEC | ||
| Jan 2, 2020 | Jan 3, 2020 | PGEN | Chief Science Officer | Sold | 3,533 | $5.60 | $20k | 128,584 | SEC |
| Dec 31, 2019 | Jan 3, 2020 | PGEN | Chief Science Officer | Exercised or settledRestricted Stock Units | 14,340 | 14,340 | SEC | ||
| Dec 31, 2019 | Jan 3, 2020 | PGEN | Chief Science Officer | Exercised options | 14,340 | 132,117 | SEC | ||
| Oct 1, 2019 | Oct 2, 2019 | PGEN | Chief Science Officer | Sold | 3,658 | $5.50 | $20k | 117,777 | SEC |
| Sep 30, 2019 | Oct 2, 2019 | PGEN | Chief Science Officer | Exercised or settledRestricted Stock Units | 14,341 | 28,680 | SEC | ||
| Sep 30, 2019 | Oct 2, 2019 | PGEN | Chief Science Officer | Exercised options | 14,341 | 121,435 | SEC | ||
| Jul 1, 2019 | Jul 2, 2019 | PGEN | Chief Science Officer | Sold | 3,527 | $7.76 | $27k | 107,094 | SEC |
| Jun 30, 2019 | Jul 2, 2019 | PGEN | Chief Science Officer | Exercised or settledRestricted Stock Units | 14,341 | 43,021 | SEC | ||
| Jun 30, 2019 | Jul 2, 2019 | PGEN | Chief Science Officer | Exercised options | 14,341 | 110,621 | SEC | ||
| Apr 9, 2019 | Apr 11, 2019 | PGEN | Chief Science Officer | AwardedRestricted Stock Units | 57,362 | 57,362 | SEC | ||
| Mar 5, 2019 | Mar 6, 2019 | PGEN | Chief Science Officer | Sold | 227,800 | $4.19 | $954k | 41,705 | SEC |
| Feb 7, 2019 | Feb 11, 2019 | PGEN | Chief Science Officer | Exercised or settledOption to Purchase Common Stock (Right to Buy) | 2,969 | 0 | SEC | ||
| Feb 7, 2019 | Feb 11, 2019 | PGEN | Chief Science Officer | Exercised options | 2,969 | $3.17 | $9k | 96,280 | SEC |
| Jan 4, 2019 | Jan 8, 2019 | PGEN | Chief Science Officer | AwardedRestricted Stock Units | 75,758 | 75,758 | SEC | ||
| Jan 4, 2019 | Jan 8, 2019 | PGEN | Chief Science Officer | Awarded | 13,774 | 93,311 | SEC | ||
| Jan 3, 2019 | Jan 4, 2019 | PGEN | Chief Science Officer | Sold | 2,944 | $7.07 | $21k | 79,537 | SEC |
| Jan 2, 2019 | Jan 4, 2019 | PGEN | Chief Science Officer | Exercised or settledRestricted Stock Units | 9,766 | 29,297 | SEC | ||
| Jan 2, 2019 | Jan 4, 2019 | PGEN | Chief Science Officer | Exercised options | 9,766 | 82,481 | SEC | ||
| Dec 31, 2018 | Jan 3, 2019 | PGEN | Chief Science Officer | Sold | 30,000 | $6.36 | $191k | 72,715 | SEC |
| Jan 2, 2018 | Jan 8, 2018 | PGEN | Chief Science Officer | AwardedRestricted Stock Units | 39,063 | 39,063 | SEC | ||
| Oct 16, 2017 | Oct 17, 2017 | PGEN | Chief Science Officer | Exercised or settledOption to Purchase Common Stock (Right to Buy) | 38,598 | 0 | SEC | ||
| Oct 16, 2017 | Oct 17, 2017 | PGEN | Chief Science Officer | Exercised options | 38,598 | $2.64 | $102k | 102,715 | SEC |
| Feb 2, 2017 | Feb 6, 2017 | PGEN | Chief Science Officer | AwardedOption to Purchase Common Stock (Right to Buy) | 100,000 | 100,000 | SEC | ||
| Dec 3, 2015 | Dec 7, 2015 | PGEN | Chief Science Officer | Returned to the companyOption to Purchase Common Stock (Right to Buy) | 64,117 | 0 | SEC | ||
| Dec 3, 2015 | Dec 7, 2015 | PGEN | Chief Science Officer | Awarded | 64,117 | $1.29 | $83k | 64,117 | SEC |
| May 13, 2014 | May 13, 2014 | PGEN | Chief Science Officer | Bought | 640 | $15.60 | $10k | 2,440 | SEC |
| Mar 20, 2014 | Mar 24, 2014 | PGEN | Chief Science Officer | AwardedOption to Purchase Common Stock (Right to Buy) | 350,000 | 350,000 | SEC | ||
| Aug 13, 2013 | Aug 15, 2013 | PGEN | Chief Science Officer | Bought | 1,800 | $16.00 | $29k | 1,800 | SEC |
| Aug 13, 2013 | Aug 15, 2013 | PGEN | Chief Science Officer | ConvertedSeries D Convertible Preferred Stock | 1,480 | 0 | SEC | ||
| Aug 13, 2013 | Aug 15, 2013 | PGEN | Chief Science Officer | Converted | 900 | 79,340 | SEC |
Sales and notices (8)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jan 6, 2020 | Jan 7, 2020 | PGEN | Chief Science Officer | Form 4 sale | 5,416 | $32k | 3.5% | Plan not stated | SEC |
| Jan 3, 2020 | Jan 6, 2020 | PGEN | Chief Science Officer | Form 4 sale | 2,986 | $17k | 2.2% | Plan not stated | SEC |
| Jan 2, 2020 | Jan 3, 2020 | PGEN | Chief Science Officer | Form 4 sale | 3,533 | $20k | 2.7% | Plan not stated | SEC |
| Oct 1, 2019 | Oct 2, 2019 | PGEN | Chief Science Officer | Form 4 sale | 3,658 | $20k | 3.0% | Plan not stated | SEC |
| Jul 1, 2019 | Jul 2, 2019 | PGEN | Chief Science Officer | Form 4 sale | 3,527 | $27k | 3.2% | Plan not stated | SEC |
| Mar 5, 2019 | Mar 6, 2019 | PGEN | Chief Science Officer | Form 4 sale | 227,800 | $954k | 84.5% | Unusual | SEC |
| Jan 3, 2019 | Jan 4, 2019 | PGEN | Chief Science Officer | Form 4 sale | 2,944 | $21k | 3.6% | Plan not stated | SEC |
| Dec 31, 2018 | Jan 3, 2019 | PGEN | Chief Science Officer | Form 4 sale | 30,000 | $191k | 29.2% | Unusual | SEC |